Eiger BioPharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
Eiger BioPharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively BuyingEiger BioPharmaceuticals 和其他两只细价股内部人士正在积极买入
The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Eiger BioPharmaceuticals
The Trade: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Director Thomas J. Dietz bought a total of 50,000 shares at an average price of $1.43. To acquire these shares, it cost around $71.58 thousand. What'
风险提示：以上内容仅作为作者或者嘉宾的观点，不代表富途的任何立场，不构成与富途相关的任何投资建议。在作出任何投资决定前，投资者应根据自身情况考虑投资产品相关的风险因素，并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性，对此富途不做任何保证和承诺。